The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Microglial VEGF Receptor Response Is an Integral Chemotactic Component in Alzheimer's Disease Pathology
Open accessAbstract
We hypothesize that microglial chemotactic responses to amyloid-β peptide (Aβ 1–42) serve as an early and integral component of inflammatory response in Alzheimer's disease (AD) brain. This study reports a receptor for vascular endothelial growth factor (VEGF), termed VEGF-1 (Flt-1), subserves microglial chemotactic responses induced by Aβ 1–42 stimulation,in vivo and in vitro. Expression of Flt-1 was significantly increased in tissue obtained from AD patients [compared with tissue from nondemented (ND) individuals], in Aβ 1–42-injected rat hippocampus, and in peptide-stimulated human microglia. Single and double immunohistochemical staining demonstrated marked immunoreactivity, for both Flt-1 and its ligand VEGF, in association with microglia and Aβ deposits in AD, but not ND, brain tissue. Functionally, treatment with anti-Flt-1 antibody was highly effective in inhibiting microglial mobility and chemotactic responses measured in vitro using a transwell migration assay.In vivo, transplanted enhanced green fluorescent protein (EGFP)-labeled microglia exhibited Flt-1-dependent chemotaxis induced by peptide injection with anti-Flt-1 effective in blocking migration of cells. Importantly, anti-Flt-1 reduction of microglial mobility was neuroprotective in peptide-injected hippocampus and associated with a significant increase in numbers of viable hippocampal neurons. The results of this study suggest critical functional roles for Flt-1 in mediating microglial chemotactic inflammatory responses which contribute to pathological conditions in AD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, upregulation of Flt-1 has been observed in the entorhinal cortical sections from human AD brain and in human microglia cells following treatment with Aβ42.36”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [36]
In the citing paper
“The growth factor VEGF, along with its receptor Flt-1, which is expressed on microglia, has also been implicated in the microglial chemotactic response to Aβ deposits through both in vitro and in vivo experiments [86].”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A., & Marmé, D. (1996) · Blood · doi:10.1182/blood.v87.8.3336.bloodjournal8783336 · Cited by 1,350
Neurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770
Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Corneal avascularity is due to soluble VEGF receptor-1
Ambati, B. K., Nozaki, M., Singh, N., Takeda, A., Jani, P. D., Suthar, T., Albuquerque, R., Richter, E. R., Sakurai, E., Newcomb, M. T., et al. (2006) · Nature · doi:10.1038/nature05249 · Cited by 703
Spires, T. L., Meyer-Luehmann, M., Stern, E. A., McLean, P. J., Skoch, J., Nguyen, P. T., Bacskai, B. J., & Hyman, B. T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1879-05.2005 · Cited by 550 · cited 2×
“Microglial VEGF Receptor Response Is an Integral”
BackgroundMicrovascular injury and blood–brain barrier leakage in Alzheimer's disease
Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487
Migration and differentiation of neural precursor cells can be directed by microglia
Aarum, J., Sandberg, K., Haeberlein, S. L. B., & Persson, M. A. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237050100 · Cited by 450
Cited by
Sorted by citations
Microglia development and function
Nayak, D., Roth, T. L., & McGavern, D. B. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120240 · Cited by 1,154
Microglial dysfunction in brain aging and Alzheimer's disease
Mosher, K. I., & Wyss-Coray, T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.008 · Cited by 618
Retinal microglia: Just bystander or target for therapy?
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M., & Langmann, T. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.004 · Cited by 570
Nitric Oxide Signaling in Brain Function, Dysfunction, and Dementia
Steinert, J. R., Chernova, T., & Forsythe, I. D. (2010) · The Neuroscientist · doi:10.1177/1073858410366481 · Cited by 471
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
Janelidze, S., Mattsson, N., Stomrud, E., Lindberg, O., Palmqvist, S., Zetterberg, H., Blennow, K., & Hansson, O. (2018) · Neurology · doi:10.1212/wnl.0000000000006082 · Cited by 359
Pericyte-Endothelial Interactions in the Retinal Microvasculature
Hu, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197413 · Cited by 230
Serrano-Pozo, A., Muzikansky, A., Gómez-Isla, T., Growdon, J. H., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182933788 · Cited by 226
Thurgur, H., & Pinteaux, E. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.06.046 · Cited by 188
Dirscherl, K., Karlstetter, M., Ebert, S., Kraus, D., Hlawatsch, J., Walczak, Y., Moehle, C., Fuchshofer, R., & Langmann, T. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-3 · Cited by 175
VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration
Carmeliet, P., & de Almodovar, C. R. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1283-7 · Cited by 173
Mahoney, E. R., Dumitrescu, L., Moore, A. M., Cambronero, F. E., De Jager, P. L., Koran, M. E. I., Petyuk, V. A., Robinson, R. A. S., Goyal, S., Schneider, J. A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0458-5 · Cited by 150
Ohlin, K. E., Francardo, V., Lindgren, H. S., Sillivan, S. E., O’Sullivan, S. S., Luksik, A. S., Vassoler, F. M., Lees, A. J., Konradi, C. L., & Cenci, M. A. (2011) · Brain · doi:10.1093/brain/awr165 · Cited by 140
Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid β
Kauppinen, T. M., Suh, S., Higashi, Y., Berman, A. E., Escartin, C., Won, S., Wang, C., Cho, S.-H., Gan, L., & Swanson, R. A. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-152 · Cited by 112
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Jeon, H., Kim, J., Kim, J., Lee, W., Lee, M., & Suk, K. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-149 · Cited by 107
Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers
Brase, L., You, S., Albanus, R. D., Del‐Aguila, J. L., Dai, Y., Novotny, B. C., Soriano‐Tárraga, C., Dykstra, T., Fernández, M. V., Budde, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37437-5 · Cited by 104
Hu, H., Parlier, R., Shen, J.-K., Lutty, G. A., & Vinores, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071808 · Cited by 97
Ryu, J. K., Cho, T., Choi, H. B., Jantaratnotai, N., & McLarnon, J. G. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0339-z · Cited by 82
Self-citationYan, L., Lee, S., Lazzaro, D. R., Aranda, J., Grant, M. B., & Chaqour, B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.646950 · Cited by 73
VEGFR1 and VEGFR2 in Alzheimer’s Disease
Harris, R., Miners, J. S., Allen, S. J., & Love, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170745 · Cited by 70
Block of Purinergic P2X7R Inhibits Tumor Growth in a C6 Glioma Brain Tumor Animal Model
Ryu, J. K., Jantaratnotai, N., Serrano‐Pérez, M. C., McGeer, P. L., & McLarnon, J. G. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318201d4d4 · Cited by 71
Self-citationRosito, M., Deflorio, C., Limatola, C., & Trettel, F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4046-11.2012 · Cited by 68
Ryu, J. K., Cho, T., Wang, Y. T., & McLarnon, J. G. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-39 · Cited by 68
Self-citationSankar, S. B., Pybus, A. F., Liew, A. Y., Sanders, B., Shah, K. J., Wood, L. B., & Buckley, E. M. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.018 · Cited by 65
Hunter, M., Spiller, K. J., Dominique, M. A., Xu, H. W., Hunter, F. W., Fang, T., Canter, R. G., Roberts, C. J., Ransohoff, R. M., Trojanowski, J. Q., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01239-x · Cited by 68
Liu, H., Wang, J., Wang, J., Wang, P., & Xue, Y. (2015) · Brain Research · doi:10.1016/j.brainres.2015.05.035 · Cited by 63
Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction
Bandyopadhyay, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.653334 · Cited by 64
VEGFR2 alteration in Alzheimer’s disease
Cho, S.-J., Park, M. H., Han, C., Yoon, K., & Koh, Y. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-18042-1 · Cited by 61
Lizano, P. L., Keshavan, M. S., Tandon, N., Mathew, I. T., Mothi, S. S., Montrose, D. M., & Yao, J. K. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.12.001 · Cited by 59
Falk, T., Gonzalez, R. T., & Sherman, S. J. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11082875 · Cited by 57
Lelli, A., Gervais, A., Colin, C., Chéret, C., de Almodóvar, C. R., Carmeliet, P., Krause, K., Boillée, S., & Mallat, M. (2013) · Glia · doi:10.1002/glia.22540 · Cited by 60
Multiple neurotrophic effects of VEGF on cultured neurons
Sanchez, A. C., Wadhwani, S., & Grammas, P. (2010) · Neuropeptides · doi:10.1016/j.npep.2010.04.002 · Cited by 58
Wang, S., Zhang, X., Zhai, L., Sheng, X., Zheng, W., Chu, H., & Zhang, G. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1032-3 · Cited by 52
VEGF counteracts amyloid-β-induced synaptic dysfunction
Martin, L., Bouvet, P., Chounlamountri, N., Watrin, C., Besançon, R., Pinatel, D., Meyronet, D., Honnorat, J., Buisson, A., Salin, P. A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109121 · Cited by 52
Altered expression of Notch1 in Alzheimer's disease
Cho, S.-J., Yun, S., Jo, C., Jeong, J., Park, M. H., Han, C., & Koh, Y. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224941 · Cited by 49
Iida, T., Yoshikawa, T., Matsuzawa, T., Naganuma, F., Nakamura, T., Miura, Y., Mohsen, A. S., Harada, R., Iwata, R., & Yanai, K. (2015) · Glia · doi:10.1002/glia.22812 · Cited by 50
Hosono‐Fukao, T., Ohtake‐Niimi, S., Hoshino, H., Britschgi, M., Akatsu, H., Hossain, M. M., Nishitsuji, K., Kuppevelt, T. H. V., Kimata, K., Michikawa, M., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.015 · Cited by 51
VEGF receptor‐1 modulates amyloid β 1–42 oligomer‐induced senescence in brain endothelial cells
Angom, R. S., Wang, Y., Wang, E., Pal, K., Bhattacharya, S., Watzlawik, J. O., Rosenberry, T. L., Das, P., & Mukhopadhyay, D. (2018) · The FASEB Journal · doi:10.1096/fj.201802003r · Cited by 49
Self-citationThe Diverse Roles of TIMP-3: Insights into Degenerative Diseases of the Senescent Retina and Brain
Dewing, J. M., Carare, R. O., Lotery, A. J., & Ratnayaka, J. A. (2019) · Cells · doi:10.3390/cells9010039 · Cited by 46
Seto, M., Dumitrescu, L. C., Mahoney, E. R., Sclafani, A. M., Jager, P. L. D., Menon, V., Koran, M. E. I., Robinson, R. A. S., Ruderfer, D. M., Cox, N. J., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.01.010 · Cited by 40
He, J., Wang, H., Liu, Y., Li, W., Kim, D. J., & Hu, H. (2015) · Journal of Ophthalmology · doi:10.1155/2015/605946 · Cited by 44
Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer’s disease
Yang, H., Yau, W. W., Carlyle, B. C., Trombetta, B. A., Zhang, C. M., Shirzadi, Z., Schultz, A. P., Pruzin, J. J., Fitzpatrick, C. D., Kirn, D. R., et al. (2024) · Brain · doi:10.1093/brain/awae034 · Cited by 43
Couturier, A., Bousquet, E., Zhao, M., Naud, M., Klein, C., Jonet, L., Tadayoni, R., de Kozak, Y., & Béhar‐Cohen, F. (2014) · PubMed Central · Cited by 42
Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
Bjorkli, C., Sandvig, A., & Sandvig, I. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00272 · Cited by 41
Bürger, S., Noack, M., Kirazov, L., Kirazov, E. P., Naydenov, C. L., Kouznetsova, E., Yafai, Y., & Schliebs, R. (2009) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2009.06.011 · Cited by 42
HIV integration in the human brain is linked to microglial activation and 3D genome remodeling
Plaza-Jennings, A. L., Valada, A., O’Shea, C. P., Iskhakova, M., Hu, B., Javidfar, B., Hutta, G. B., Lambert, T. Y., Murray, J., Kassim, B. S., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.11.016 · Cited by 42
Prodjohardjono, A., Vidyanti, A. N., Susianti, N. A., Sudarmanta, Sutarni, S., & Setyopranoto, I. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239370 · Cited by 39
Cellular and molecular mechanisms involved in the neuroprotective effects of VEGF on motoneurons
Lladó, J., Tolosa, L., & Olmos, G. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00181 · Cited by 39
Inflammatory Biomarkers Aid in Diagnosis of Dementia
Erhardt, E. B., Adair, J. C., Knoefel, J. E., Caprihan, A., Prestopnik, J., Thompson, J., Hobson, S., Siegel, D., & Rosenberg, G. A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.717344 · Cited by 42
Cho, T., Ryu, J. K., Taghibiglou, C., Ge, Y., Chan, A. W., Liu, L., Lu, J., McLarnon, J. G., & Wang, Y. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076860 · Cited by 40
Self-citationZhao, P., Wang, Y., Yin, S., & Zhang, N. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.237121 · Cited by 35
Self-citationHIV-1 Tat Disrupts CX3CL1-CX3CR1 Axis in Microglia via the NF-κBYY1 Pathway
Duan, M., Yao, H., Cai, Y. C., Liao, K., Seth, P., & Buch, S. J. (2014) · Current HIV Research · doi:10.2174/1570162x12666140526123119 · Cited by 34
Ceci, C., Lacal, P. M., Barbaccia, M. L., Mercuri, N. B., Graziani, G., & Ledonne, A. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107101 · Cited by 36
Chiarini, A., Whitfield, J., Bonafini, C., Chakravarthy, B., Armato, U., & Prà, I. D. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100471 · Cited by 35
Comparison of Vascular Perturbations in an A β ‐Injected Animal Model and in AD Brain
Jantaratnotai, N., Ryu, J. K., Schwab, C., McGeer, P. L., & McLarnon, J. G. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/918280 · Cited by 33
Self-citationAlvarez, X. A., Álvarez, I., Aleixandre, M., Linares, C., Muresanu, D. F., Winter, S., & Moessler, H. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-160477 · Cited by 33
Harcha, P. A., Garcés, P., Arredondo, C., Fernández, G. R., Sáez, J. C., & van Zundert, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041924 · Cited by 38
Chen, C.-C. V., Chen, Y., Hsiao, H., Chang, C., & Chern, Y. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-47 · Cited by 32
Ping, S., Qiu, X., Kyle, M. M., Hughes, K., Longo, J. A., & Zhao, L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104561 · Cited by 32
McLarnon, J. G. (2014) · BioMed Research International · doi:10.1155/2014/923670 · Cited by 30
Self-citationRoles of purinergic P2X 7 receptor in glioma and microglia in brain tumors
McLarnon, J. G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.004 · Cited by 30
Self-citationÉgervári, K., Potter, G., Guzmán-Hernández, M. L., Salmon, P., Soto-Ribeiro, M., Kastberger, B., Balla, T., Wehrle‐Haller, B., & Kiss, J. Z. (2015) · Glia · doi:10.1002/glia.22939 · Cited by 27
Li, L., Zhu, M., Wu, W., Qin, B., Gu, J., Tu, Y., Chen, J., Liu, D., Shi, Y., Liu, X., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29041 · Cited by 28
Assaying Microglia Functions In Vitro
Maguire, E., Connor‐Robson, N., Shaw, B., O’Donoghue, R., Stöberl, N., & Hall‐Roberts, H. (2022) · Cells · doi:10.3390/cells11213414 · Cited by 31
Progranulin promotes activation of microglia/macrophage after pilocarpine-induced status epilepticus
Zhu, S., Tai, C., Petkau, T. L., Zhang, S., Liao, C., Dong, Z., Wen, W., Chang, Q., Wang, Y. T., MacVicar, B. A., et al. (2013) · Brain Research · doi:10.1016/j.brainres.2013.07.023 · Cited by 27
Self-citationIdentification of Biomarkers Associated With Alzheimer’s Disease by Bioinformatics Analysis
Zhao, Y., Tan, W., Sheng, W., & Li, X. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515588181 · Cited by 25
Nishitsuji, K. (2018) · Glycoconjugate Journal · doi:10.1007/s10719-018-9833-8 · Cited by 28
Lee, G., Kim, H., Sang-Yong, H., Bhandary, B., Kim, D., Kim, M., So, B., Sun-Young, K., Jo, K.-S., Bo-Hee, L., et al. (2012) · Biological Research · doi:10.4067/s0716-97602012000400013 · Cited by 23
The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
Jeon, S. G., Lee, H., Park, H., Han, K., & Hoe, H. (2020) · Molecular Brain · doi:10.1186/s13041-020-00673-7 · Cited by 21
Serrano‐Pozo, A., Sánchez-García, M. A., Heras‐Garvin, A., March‐Díaz, R., Navarro, V., Vizuete, M., López‐Barneo, J., Vitórica, J., & Pascual, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170345 · Cited by 20
Gold, A., Kaye, S. D., Gao, J., & Zhu, J. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00370 · Cited by 20
Does hearing aid use affect audiovisual integration in mild hearing impairment?
Gieseler, A., Tahden, M. A. S., Thiel, C. M., & Colonius, H. (2018) · Experimental Brain Research · doi:10.1007/s00221-018-5206-6 · Cited by 19
Bürger, S., Yafai, Y., Bigl, M., Wiedemann, P., & Schliebs, R. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.07.231 · Cited by 20
Yao, H., Duan, M., Yang, L., & Buch, S. J. (2013) · The FASEB Journal · doi:10.1096/fj.12-219600 · Cited by 19
Hao, C., Han, M., Wang, W., Yang, C., Wang, J., Guo, Y., Xu, T., Zhang, L., & Li, C. (2023) · Marine Life Science & Technology · doi:10.1007/s42995-023-00172-3 · Cited by 20
Alzheimer's disease and type 2 diabetes: Two diseases, one common link?
Bartl, J., Monoranu, C., Schilling, A.-K., Kolter, J. F., Riederer, P., & Grünblatt, E. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.650204 · Cited by 17
Lei, Z., Krishnamachary, B., Khan, N., Ji, Y., Li, Y., Li, H., Brunner, K., Faden, A. I., Jones, J. W., & Wu, J. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.005 · Cited by 15
Mendonça, M. C. P., Soares, E. S., Stávale, L. M., Irazusta, S. P., & da Cruz‐Höfling, M. A. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.05.015 · Cited by 16
Lizano, P. L., Yao, J. K., Tandon, N., Mothi, S. S., Montrose, D. M., & Keshavan, M. S. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.11.015 · Cited by 15
Meyer, P., Savard, M., Poirier, J., Morgan, D., Breitner, J. C. S., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.05.007 · Cited by 15
Emerging Roles of Microglia in Blood-Brain Barrier Integrity in Aging and Neurodegeneration
Zhang, S., Meng, R., Jiang, M., Qing, H., & Ni, J. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230203103910 · Cited by 16
VEGF controls microglial phagocytic response to amyloid-β
Gea, P. D., Benkeder, S., Bouvet, P., Aimard, M., Chounlamountri, N., Honnorat, J., Do, L.-D., & Meissirel, C. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1264402 · Cited by 19
Wu, Y., Libby, J. B., Dumitrescu, L. C., Jager, P. L. D., Menon, V., Schneider, J. A., Bennett, D. A., & Hohman, T. J. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14419 · Cited by 15
Kim, Y. J., Park, S. Y., Koh, Y. J., & Lee, J. (2021) · Plants · doi:10.3390/plants10040688 · Cited by 14
Daga, K. R., Larey, A. M., Morfin, M. G., Chen, K., Bitarafan, S., Carpenter, J. M., Hynds, H. M., Hines, K. M., Wood, L. B., & Marklein, R. A. (2024) · Journal of Biological Engineering · doi:10.1186/s13036-024-00449-w · Cited by 14
Sanharawi, M. E., Touchard, E., Bénard, R., Bigey, P., Escriou, V., Mehanna, C., Naud, M.-C., Berdugo, M., Jeanny, J. C., & Béhar‐Cohen, F. (2013) · Gene Therapy · doi:10.1038/gt.2013.36 · Cited by 13
Chadi, G., Maximino, J. R., & de Oliveira, G. P. (2009) · Journal of Molecular Histology · doi:10.1007/s10735-009-9235-0 · Cited by 13
Placental growth factor: a tissue modelling factor with therapeutic potentials in neurology?
Chaballe, L., Schoenen, J. E., & Franzen, R. (2011) · PubMed · Cited by 13
Sakurai, M., MORITA, T., Takeuchi, T., & Shimada, A. (2013) · American Journal of Veterinary Research · doi:10.2460/ajvr.74.5.763 · Cited by 13
Azizan, Z., Zali, H., Mirmotalebisohi, S. A., Bazrgar, M., & Ahmadiani, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304410 · Cited by 11
Liu, J., Yu, W., Ma, C., Li, T., Liang, Y., Su, S., Zhong, G., Xie, Z., Wu, Q., Chen, J., et al. (2023) · Planta Medica · doi:10.1055/a-2014-6061 · Cited by 13
Winfree, R. L., Nolan, E., Blennow, K., Zetterberg, H., Gifford, K. A., Pechman, K. R., Schneider, J. A., Bennett, D. A., Petyuk, V., Jefferson, A. L., et al. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.12.010 · Cited by 11
Wang, X., Liu, L., Jiang, X., Saredy, J., Xi, H., Cueto, R., Sigler, D., Khan, M., Wu, S., Ji, Y. H., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01311-9 · Cited by 8
The brain neurovascular epigenome and its association with dementia
Ziegler, K. C., Askarova, A., Gergian, C., Yaa, R. M., van Dalen, J. D., Transfeld, J. L., Zoppi, F., Du, J., Clode, D., Rahbar, F., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.10.001 · Cited by 17
Poorgholam, P., Yaghmaei, P., Noureddini, M., & Hajebrahimi, Z. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01200-y · Cited by 8
Zhou, G., Xiang, T., Xu, Y., He, B., Wu, L., Zhu, G., Xie, J., Yao, L., & Xiao, Z. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175446 · Cited by 8
Alvarez, X. A., Álvarez, I., Martinez, A., Romero, I., Benito, C., Suarez, I., Mourente, S., Fantini, M., Figueroa, J., Aleixandre, M., et al. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa046 · Cited by 8
Cheng, S.-Y., Malachi, A., Cipi, J., Ma, S., Brush, R. S., Agbaga, M., & Punzo, C. (2021) · Biomolecules · doi:10.3390/biom11060871 · Cited by 7
He, R. Q., Cheng, J., Qiu, Y., Hu, Y., Liu, J., Wang, T., & Cao, X. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112512 · Cited by 6
CSF pTDP-43 across the Alzheimer's spectrum: Links to amyloid, APOE and vasculopathy
Rafiee, Z., Pocevičiūtė, D., Santiago, J., Mahmoud, R., Janelidze, S., Hansson, O., & Wennström, M. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107193 · Cited by 4
Targeting TREM2 signaling shows limited impact on cerebrovascular calcification
Sridhar, S., Zhou, Y., Ibrahim, A., Bertazzo, S., Wyss, T., Swain, A., Maheshwari, U., Huang, S., Colonna, M., & Keller, A. (2024) · Life Science Alliance · doi:10.26508/lsa.202402796 · Cited by 4
Metadata
- Authors
- Ryu, J. K., Cho, T., Choi, H. B., Wang, Y. T., & McLarnon, J. G.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- McLarnon, James G.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-01-07
- Volume
- 29
- Issue
- 1
- Pages
- 3-13
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6664925
- OpenAlex
- W2022811766
- Cited by
- 121
- References
- 45
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 12 · 2023: 10 · 2022: 4 · 2021: 9 · 2020: 6 · 2019: 6 · 2018: 9 · 2017: 4 · 2016: 1 · 2015: 9 · 2014: 6 · 2013: 13 · 2012: 8
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- Fondation pour la Recherche sur Alzheimer
- Department of Psychiatry, Faculty of Medicine, University of British Columbia
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, microglia, amyloid-beta, microglial chemotaxis, neuroinflammation, microglial migration, neuroprotection, hippocampus, amyloid-beta deposition
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Analysis of Variance, Animals, Cell Movement, Cells, Cultured, Disease Models, Animal, Glial Fibrillary Acidic Protein, Hippocampus, HLA-DR Antigens, Humans, Mice, Transgenic, Middle Aged, Peptide Fragments, Phosphopyruvate Hydratase, Postmortem Changes, RNA, Messenger, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Rats, Sprague-Dawley, Microglia, Entorhinal Cortex, CD11b Antigen, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-1, Green Fluorescent Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review